Peripherally inserted central catheter (PICC)-related thrombosis in critically ill patients

Journal of Vascular Access

Volumn 15, Issue 5, 2014, Pages 329-337

  Zochios, Vasileios ^a   Umar, Imraan ^b   Simpson, Nicola ^c   Jones, Nicola ^a  

^a PAPWORTH HOSPITAL   (United Kingdom)

^b LEICESTER ROYAL INFIRMARY   (United Kingdom)

^c Kettering General Hospital NHS Trust   (United Kingdom)

Author keywords

Critical illness; PICC; Upper extremity thrombosis

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ANGIOPLASTY; ANTICOAGULANT THERAPY; ARTIFICIAL VENTILATION; BACTEREMIA; BLOOD CLOT LYSIS; CATHETER INFECTION; CATHETER THROMBOSIS; CENTRAL VENOUS CATHETER; CENTRALLY INSERTED CENTRAL VENOUS CATHETER; COMPUTER ASSISTED TOMOGRAPHY; CRITICAL ILLNESS; DEEP VEIN THROMBOSIS; DOPPLER ECHOGRAPHY; HUMAN; LUNG EMBOLISM; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; PHLEBOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; POSTTHROMBOSIS SYNDROME; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; SYSTEMATIC REVIEW (TOPIC); THORAX RADIOGRAPHY; THROMBECTOMY; UPPER EXTREMITY DEEP VEIN THROMBOSIS; VASCULAR ACCESS; ADVERSE EFFECTS; CATHETER OBSTRUCTION; CATHETERIZATION; CENTRAL VENOUS CATHETERIZATION; DEVICE REMOVAL; DEVICES; ECHOGRAPHY; INDWELLING CATHETER; PREDICTIVE VALUE; RISK ASSESSMENT; TREATMENT OUTCOME;

ANTICOAGULANTS; CATHETER OBSTRUCTION; CATHETERIZATION, CENTRAL VENOUS; CATHETERIZATION, PERIPHERAL; CATHETERS, INDWELLING; CENTRAL VENOUS CATHETERS; CRITICAL ILLNESS; DEVICE REMOVAL; HUMANS; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; UPPER EXTREMITY DEEP VEIN THROMBOSIS;

EID: 84908395095     PISSN: 11297298     EISSN: 17246032     Source Type: Journal    
DOI: 10.5301/jva.5000239     Document Type: Review

References (65)

1. Marnejon T, Angelo D, Abu Abdou A, Gemmel D. Risk factors associated with peripherally inserted central venous catheters. J Vasc Access. 2012;13(2):231-238.
2. Wilson TJ, Brown DL, Meurer WJ, Stetler WR Jr, Wilkinson DA, Fletcher JJ. Risk factors associated with peripherally inserted central venous catheters in neurological intensive care patients. Intensive Care Med. 2012;38:272-278.
3. Trerotola SO, Stavropoulos SW, Mondschein JI, et al. Triplelumen peripherally inserted central catheter in patients in the critical care unit: prospective evaluation. Radiology. 2010;256(1):312-320.
4. Hoyt DB, Swegle JR. Deep venous thrombosis in the surgical intensive care unit. Surg Clin North Am. 1991;71(4):811-830.
5. Ibrahim EH, Iregui M, Prentice D, Sherman G, Kollef MH, Shannon W. Deep vein thrombosis during prolonged mechanical ventilation despite prophylaxis. Crit Care Med. 2002;30(4):771-774.
6. Cook D, Crowther M, Meade M, et al. Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors. Crit Care Med. 2005;33(7): 1565-1571.
7. Evans RS, Sharp JH, Linford LH, et al. Risk of symptomatic DVT associated with peripherally inserted central catheters. Chest. 2010;138(4):803-810.
8. Liem TK, Yanit KE, Moseley SE, et al. Peripherally inserted central catheter usage patterns and associated symptomatic upper extremity venous thrombosis. J Vasc Surg. 2012;55(3):761-767.
9. Abdullah BJ, Mohammad N, Sangkar JV, et al. Incidence of upper limb venous thrombosis associated with peripherally inserted central catheters (PICC). Br J Radiol. 2005; 78(931):596-600.
10. Tran H, Arellano M, Chamsuddin A, et al. Deep venous thromboses in patients with hematological malignancies after peripherally inserted central venous catheters. Leuk Lymphoma. 2010;51(8):1473-1477.
11. Lobo BL, Vaidean G, Broyles J, Reaves AB, Shorr RI. Risk of venous thromboembolism in hospitalized patients with peripherally inserted central catheters. J Hosp Med. 2009; 4(7):417-422.
12. Nash EF, Helm EJ, Stephenson A, Tullis E. Incidence of deep vein thrombosis associated with peripherally inserted central catheters in adults with cystic fibrosis. J Vasc Interv Radiol. 2009;20(3):347-351.
13. Paauw JD, Borders H, Ingalls N, et al. The incidence of PICC line-associated thrombosis with and without the use of prophylactic anticoagulants. JPEN J Parenter Enteral Nutr. 2008;32(4):443-447.
14. Itkin M, Mondshein JI, Stavropoulos SW, Shlansky-Goldberg RD, Soulen MC, Trerotola SO. Peripherally inserted central catheter thrombosis-reverse tapered versus nontapered catheters: a randomized controlled study. J Vasc Interv Radiol. 2014;25(1):85-91, e1.
15. Fletcher JJ, Stetler W, Wilson TJ. The clinical significance of peripherally inserted central venous catheter-related deep vein thrombosis. Neurocrit Care. 2011;15(3):454-460.
16. Bonizzoli M, Batacchi S, Cianchi G, et al. Peripherally inserted central venous catheters and central venous catheters related thrombosis in post-critical patients. Intensive Care Med. 2011;37(2):284-289.
17. Pittiruti M, Brutti A, Celentano D, et al. Clinical experience with power injectable peripherally inserted central catheters in intensive care patients. Crit Care. 2012;16:R21.
18. Wilson TJ, Stetler WR Jr, Fletcher JJ. Comparison of catheter- related large vein thrombosis in centrally inserted versus peripherally inserted central venous lines in the neurological intensive care unit. Clin Neurol Neurosurg. 2013; 115(7):879-882.
19. Chopra V, Anand S, Hickner A, et al. Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis. Lancet. 2013;382(9889):311-325.
20. Spronk HM, van der Voort D, Ten Cate H. Blood coagulation and the risk of atherothrombosis: a complex relationship. Thromb J. 2004;2(1):12.
21. Attia J, Ray JG, Cook DJ, Douketis J, Ginsberg JS, Geerts WH. Deep vein thrombosis and its prevention in critically ill adults. Arch Intern Med. 2001;161(10):1268-1279.
22. Cook D, Attia J, Weaver B, McDonald E, Meade M, Crowther M. Venous thromboembolic disease: an observational study in medical-surgical intensive care unit patients. J Crit Care. 2000;15(4):127-132.
23. Luce JM. The cardiovascular effects of mechanical ventilation and positive end-expiratory pressure. JAMA. 1984; 252(6):807-811.
24. Yi XL, Chen J, Li J, et al. Risk factors associated with PICC-related upper extremity venous thrombosis in cancer patients. J Clin Nurs. 2014;23(5-6):837-843.
25. Ahn DH, Illum HB, Wang DH, Sharma A, Dowell JE. Upper extremity venous thrombosis in patients with cancer with peripherally inserted central venous catheters: a retrospective analysis of risk factors. J Oncol Pract. 2013;9(1): e8-e12.
26. Evans RS, Sharp JH, Linford LH, et al. Reduction of peripherally inserted central catheter-associated DVT. Chest. 2013;143(3):627-633.
27. Grove JR, Pevec WC. Venous thrombosis related to peripherally inserted central catheters. J Vasc Interv Radiol. 2000; 11(7):837-840.
28. Borissoff JI, Spronk HM, Heeneman S, ten Cate H. Is thrombin a key player in the 'coagulation-atherogenesis' maze? Cardiovasc Res. 2009;82(3):392-403.
29. Schultz MJ, Levi M. Pulmonary coagulopathy: a potential therapeutic target in different forms of lung injury. Thorax. 2007;62(7):563-564.
30. Haitsma JJ, Schultz MJ, Hofstra JJ, et al. Ventilator-induced coagulopathy in experimental Streptococcus pneumoniae pneumonia. Eur Respir J. 2008;32(6):1599-1606.
31. Klerk CPW, Smorenburg SM, Büller HR. Thrombosis prophylaxis in patient populations with a central venous catheter: a systematic review. Arch Intern Med. 2003;163(16): 1913-1921.
32. Nifong TP, McDevitt TJ. The effect of catheter to vein ratio on blood flow rates in a simulated model of peripherally inserted central venous catheters. Chest. 2011;140(1): 48-53.
33. Baskin JL, Pui CH, Reiss U, et al. Management of occlusion and thrombosis associated with long-term indwelling central venous catheters. Lancet. 2009;374(9684):159-169.
34. Rooden CJ, Tesselaar ME, Osanto S, Rosendaal FR, Huisman MV. Deep vein thrombosis associated with central venous catheters - a review. J Thromb Haemost. 2005;3(11):2409-2419.
35. Fletcher JJ, Stetler W, Wilson TJ. The clinical significance of peripherally inserted central venous catheter-related deep vein thrombosis. Neurocrit Care. 2011;15(3):454-460.
36. Prandoni P, Polistena P, Bernardi E, et al. Upper-extremity deep vein thrombosis. Risk factors, diagnosis, and complications. Arch Intern Med. 1997;157(1):57-62.
37. Malinoski DJ, Ewing T, Patel MS, et al. The natural history of upper extremity deep venous thromboses in critically ill surgical and trauma patients: what is the role of anticoagulation? J Trauma. 2011;71(2):316-321, discussion 321-322.
38. Mehall JR, Saltzman DA, Jackson RJ, Smith SD. Fibrin sheath enhances central venous catheter infection. Crit Care Med. 2002;30(4):908-912.
39. Levi M, van der Poll T, Büller HR. Bidirectional relation between inflammation and coagulation. Circulation. 2004;109(22):2698-2704.
40. Thornburg CD, Smith PB, Smithwick ML, Cotten CM, Benjamin DK Jr. Association between thrombosis and bloodstream infection in neonates with peripherally inserted catheters. Thromb Res. 2008;122(6):782-785.
41. Timsit JF, Farkas JC, Boyer JM, et al. Central vein catheterrelated thrombosis in intensive care patients: incidence, risks factors, and relationship with catheter-related sepsis. Chest. 1998;114(1):207-213.
42. Frasca D, Dahyot-Fizelier C, Mimoz O. Prevention of central venous catheter-related infection in the intensive care unit. Crit Care. 2010;14(2):212.
43. Ong B, Gibbs H, Catchpole I, Hetherington R, Harper J. Peripherally inserted central catheters and upper extremity deep vein thrombosis. Australas Radiol. 2006;50(5): 451-454.
44. Elman EE, Kahn SR. The post-thrombotic syndrome after upper extremity deep venous thrombosis in adults: a systematic review. Thromb Res. 2006;117(6):609-614.
45. Constans J, Salmi LR, Sevestre-Pietri MA, et al. A clinical prediction score for upper extremity deep venous thrombosis. Thromb Haemost. 2008;99(1):202-207.
46. Engelberger RP, Kucher N. Management of deep vein thrombosis of the upper extremity. Circulation. 2012;126(6): 768-773.
47. Grant JD, Stevens SM, Woller SC, et al. Diagnosis and management of upper extremity deep-vein thrombosis in adults. Thromb Haemost. 2012;108(6):1097-1108.
48. Kucher N. Clinical practice. Deep-vein thrombosis of the upper extremities. N Engl J Med. 2011;364(9):861-869.
49. Stein PD, Terrin ML, Hales CA, et al. Clinical, laboratory, roentgenographic, and electrocardiographic findings in patients with acute pulmonary embolism and no preexisting cardiac or pulmonary disease. Chest. 1991;100(3): 598-603.
50. Di Nisio M, Van Sluis GL, Bossuyt PM, Büller HR, Porreca E, Rutjes AW. Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review. J Thromb Haemost. 2010;8(4): 684-692.
51. Di Nisio M, Van Sluis GL, Bossuyt PM, Büller HR, Porreca E, Rutjes AW. Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review. J Thromb Haemost. 2010;8(4):684-692.
52. Thomas SM, Goodacre SW, Sampson FC, van Beek EJ. Diagnostic value of CT for deep vein thrombosis: results of a systematic review and meta-analysis. Clin Radiol. 2008; 63(3):299-304.
53. Sampson FC, Goodacre SW, Thomas SM, van Beek EJ. The accuracy of MRI in diagnosis of suspected deep vein thrombosis: systematic review and meta-analysis. Eur Radiol. 2007;17(1):175-181.
54. Paauw JD, Borders H, Ingalls N, et al. The incidence of PICC line-associated thrombosis with and without the use of prophylactic anticoagulants. JPEN J Parenter Enteral Nutr. 2008;32(4):443-447.
55. Meyer BM. Managing peripherally inserted central catheter thrombosis risk: a guide for clinical best practice. JAVA. 2011;16(3):144-147.
56. Ligtenberg JJ, Holman M, van Meurs M, Ter Maaten JC, Zijlstra JG. Peripherally inserted central catheters: a walk down memory lane .... Crit Care. 2012;16(2):418, author reply 418.
57. th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e419S-94S.
58. Wagman LD, Baird MF, Bennett CL, et al; National Comprehensive Cancer Network. Venous thromboembolic disease. NCCN. Clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2008;6(8):716-753.
59. Baglin T, Bauer K, Douketis J, et al. Duration of anticoagulant therapy after a first episode of unprovoked pulmonary embolus or deep vein thrombosis: guidance from the scientific and standardization committee of the international society on thrombosis and haemostasis. J Thromb Haemost. 2012;10:698-702.
60. Kearon C, Ginsberg JS, Julian JA, et al,; Fixed-Dose Heparin (FIDO) Investigators. Comparison of fixed-dose weightadjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism. JAMA. 2006;296(8):935-942.
61. Carlbom DJ, Davidson BL. Pulmonary embolism in the critically ill. Chest. 2007;132(1):313-324.
62. Clark NP. Low-molecular-weight heparin use in the obese, elderly, and in renal insufficiency. Thromb Res. 2008;123 (Suppl 1):S58-S61.
63. Zochios VA, Keeshan A. Pulmonary embolism in the mechanically ventilated critically ill patient: is it different? JICS. 2013;14(1):36-44.
64. Semba CP, Deitcher SR, Li X, Resnansky L, Tu T, McCluskey ER; Cardiovascular thrombolytic to Open Occluded Lines Investigators. Treatment of occluded central venous catheters with alteplase: results in 1,064 patients. J Vasc Interv Radiol. 2002;13(12):1199-1205.
65. Cortejoso L, Manrique-Rodríguez S, Fernández-Llamazares CM, Sanjurjo-Sáez M. Treatment and prophylaxis of catheter- related thromboembolic events in children. J Pharm Pharm Sci. 2012;15(5):632-641.